Amwell makes grant to new employee under inducement plan
Amwell (NYSE: AMWL) has granted 3,451 Restricted Stock Units (RSUs) of Class A common stock to a new employee as an employment inducement. The vesting schedule includes 25% of RSUs vesting on the first anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over the following three years. The grant was approved by Amwell's Compensation Committee under the company's Inducement Plan and complies with NYSE's Listed Company Manual Rule 303A.08.
Amwell (NYSE: AMWL) ha assegnato 3.451 Unità Azionarie Vincolate (RSU) di azioni ordinarie di Classe A a un nuovo dipendente come incentivo all'assunzione. Il piano di maturazione prevede che il 25% delle RSU maturi al primo anniversario della data di assegnazione, mentre il restante 75% maturerà in quote uguali ogni tre mesi nei successivi tre anni. L'assegnazione è stata approvata dal Comitato per la Remunerazione di Amwell nell'ambito del Piano di Incentivazione della società e rispetta la Regola 303A.08 del Manuale per le Società Quotata della NYSE.
Amwell (NYSE: AMWL) ha otorgado 3,451 Unidades de Acciones Restringidas (RSU) de acciones ordinarias Clase A a un nuevo empleado como incentivo laboral. El calendario de adquisición establece que el 25% de las RSU se consolidan en el primer aniversario de la fecha de concesión, y el 75% restante se consolida en partes iguales cada tres meses durante los siguientes tres años. La concesión fue aprobada por el Comité de Compensación de Amwell bajo el Plan de Incentivos de la empresa y cumple con la Regla 303A.08 del Manual de Empresas Cotizadas de la NYSE.
Amwell (NYSE: AMWL)은 신규 직원에게 고용 유인을 위해 클래스 A 보통주 3,451개의 제한 주식 단위(RSU)를 부여했습니다. 베스팅 일정은 부여일로부터 1주년 시점에 RSU의 25%가 베스팅되고, 나머지 75%는 이후 3년 동안 매 3개월마다 동일한 비율로 베스팅됩니다. 이 부여는 Amwell의 보상위원회가 회사의 유인 계획에 따라 승인했으며, NYSE 상장기업 매뉴얼 규칙 303A.08을 준수합니다.
Amwell (NYSE : AMWL) a attribué 3 451 unités d'actions restreintes (RSU) d'actions ordinaires de classe A à un nouvel employé en tant qu'incitation à l'embauche. Le calendrier d'acquisition prévoit que 25 % des RSU seront acquises à la première date anniversaire de la remise, les 75 % restants étant acquis par tranches égales tous les trois mois au cours des trois années suivantes. Cette attribution a été approuvée par le comité de rémunération d'Amwell dans le cadre du plan d'incitation de la société et respecte la règle 303A.08 du manuel des sociétés cotées de la NYSE.
Amwell (NYSE: AMWL) hat einem neuen Mitarbeiter 3.451 Restricted Stock Units (RSUs) von Stammaktien der Klasse A als Anreiz zur Einstellung gewährt. Der Vesting-Zeitplan sieht vor, dass 25 % der RSUs am ersten Jahrestag des Gewährungsdatums vesten, während die restlichen 75 % in gleichen Anteilen alle drei Monate über die folgenden drei Jahre vesten. Die Gewährung wurde vom Vergütungsausschuss von Amwell im Rahmen des Inducement-Plans des Unternehmens genehmigt und entspricht der Regel 303A.08 des NYSE Listed Company Manual.
- None.
- None.
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee’s employment with Amwell. The RSUs will vest as follows, subject to the employee’s continued employment through the applicable vesting date:
The grants described in this press release were approved by the Compensation Committee of the Amwell’s Board of Directors pursuant to the Amwell’s Inducement Plan and made in reliance on the employment inducement exemption under the NYSE’s Listed Company Manual Rule 303A.08. Amwell is issuing this press release pursuant to Rule 303A.08.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Media:
Angela Vogen
Press@amwell.com
Investor:
Sue Dooley
Sue.Dooley@amwell.com
Notice of Ownership
All materials contained herein are the property of American Well Corporation and are copyrighted under United States law and applicable international copyright laws and treaty provisions. The materials contained herein are not work product or "work for hire" on behalf of any third party. The materials contained herein constitute the confidential information of American Well Corporation, except for specific data elements provided by third parties, which are the confidential information of such third parties. The content contained herein results from the application of American Well proprietary processes, analytical frameworks, algorithms, business methods, solution construction aids and templates, all of which are and remain the property of American Well Corporation.
Trademark Notice
All of the trademarks, service marks and logos displayed on these materials (the "Trademark(s)") are registered and unregistered trademarks of American Well Corporation or third parties who have licensed their Trademarks to American Well Corporation. Except as expressly stated in these terms and conditions, you may not reproduce, display or otherwise use any Trademark without first obtaining American Well Corporation's written permission.
